QuarterlyIQ Insights · CVS
Price
Price, valuation, and the composite score on the same time axis. Scroll over the price chart to zoom.
Price
Daily closes. Earnings/event dots inline.
What it's worth (estimated)
A consensus fair price across 7 valuation methods, at three horizons. Current price $97.04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
No-growth: today's peer multiple on trailing earnings. The headline read.
Embeds projected growth. Leans optimistic by design. Upside context.
Long-thesis check; widest uncertainty.
By method
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Conf. |
|---|---|---|---|---|---|---|
| Mgmt guidance | 12M | $122.45 | 19.3 | 6.34 | Mgmt | 50 |
| Peer EV/EBITDA | 12M | $78.36 | 15.1 | 8.10 | TTM | 50 |
| Peer P/FCF | 12M | $122.50 | 20.9 | 5.85 | TTM | 50 |
| Peer P/E | 12M | $136.55 | 19.3 | 7.07 | TTM | 50 |
| PEG | 12M | $160.49 | 22.7 | 7.07 | TTM | 50 |
| Own P/E history | 12M | $78.71 | 11.1 | 7.07 | TTM | 50 |
| triangulated | 12M | $142.99 | 19.3 | 7.40 | Triangulated | 50 |
| Mgmt guidance | 3Y | $169.35 | 19.3 | 8.77 | Mgmt(prov.) | 52 |
| Peer P/FCF | 3Y | $52.08 | 20.9 | 2.49 | Hist. CAGR(prov.) | 52 |
| Peer P/E | 3Y | $188.85 | 19.3 | 9.78 | Analyst | 52 |
| PEG | 3Y | $221.96 | 22.7 | 9.78 | Analyst | 52 |
| Own P/E history | 3Y | $108.86 | 11.1 | 9.78 | Analyst | 52 |
| Mgmt guidance | 5Y | $210.22 | 19.3 | 10.88 | Mgmt(prov.) | 51 |
| Peer P/FCF | 5Y | $29.44 | 20.9 | 1.41 | Hist. CAGR(prov.) | 51 |
| Peer P/E | 5Y | $234.42 | 19.3 | 12.14 | Analyst | 51 |
| PEG | 5Y | $275.52 | 22.7 | 12.14 | Analyst | 51 |
| Own P/E history | 5Y | $135.13 | 11.1 | 12.14 | Analyst | 51 |
Composite score history
Daily snapshots of the composite. Zero is the dotted line. Above it leans positive.
P/E history
Monthly trailing P/E with quartile reference lines.
Composite score history currently shows a rolling 60-day window. We're extending it back through full coverage and adding a “consensus-then vs. actual-now” overlay (what our valuation estimate said on a past date versus where the price actually landed).
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.